Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-11
1996-06-11
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548533, 548537, A61K 3140, C07D20700
Patent
active
055256236
ABSTRACT:
Compositions and methods for the prevention and treatment of immunomediated inflammatory disorders, especially for those disorders associated with the respiratory tract, are provided. More particularly, a tryptase inhibitor, typically a hydroxyaroyl or hydroxyheteroaroyl substituted dipeptide, is administered. Also provided by this invention are pharmaceutical compositions, typically aerosol or topical, as well as aerosol devices for administering these compositions intranasally.
REFERENCES:
patent: 4201863 (1980-05-01), Okamoto et al.
patent: 4456595 (1984-06-01), Weller, III et al.
Katunuma, et al., 1990, "Recent Advances in Research on Tryptases and Endogenous Tryptase Inhibitors," Schwartz (ed): Neutral Proteases of Mast Cells, Monogr. Allergy, Basel, Karger, 27:pp. 51-66.
Lavens et al., (1992), Program and Abstracts, X Int'l. Congress of Eye Research, The Int'l. Soc. for Eye Research, 91:(1) (Part 2), Abstract No. 760, p. 331, "Release of Tryptase from Human Lung Mast Cells(HLMC)".
Walls et al., (1993), J. Allergy Clin Immunol., Abstract No. 462, p. 256, "Mast Cell Proteases as Mediators of Vascular Leakage and Cell Accumulation".
Lilly et al., (1992), Am. Lung Assoc. Meeting, "Ovalbumin Induced Pulmonary Inflammation Inhibits VIP Pulmonary Relaxation in Superfused Guinea Pig Lungs," p. A36.
Lilly et al., (1993), J. Clin. Invest., 91:pp. 235-243, "Peptidase Modulation of Vasoactive Intestinal Peptide Pulmonary Relaxation in Tracheal Superfused Guinea Pig Lungs".
Tam et al., (1990), Am. J. Respir. Cell Mol. Biol., 3:pp. 27-32, "Degradation of Airway Neuropeptides by Human Lung Tryptase".
Tam et al., (1990), Am. J. Respir. Cell Mol. Biol., 2:pp. 449-452, "Protease Inhibitors Potentiate Smooth Muscle Relaxation Induced by Vasoactive Intestinal Peptide in Isolated Human Bronchi".
Issekutz et al., (1990), Int. J. Immunopharmac., 12(1), :pp. 1-9, "The Effect of FUT-175 (Nafamstat Mesilate) on C3.sub.a, C4.sub.a and C5.sub.a Generation In Vitro and Inflammatory Reactions In Vivo".
Barnes, (1991), TIBS, 16:pp. 365-369, "Biochemistry of Asthma".
Spragg et al., (1988), Peptides, 9:pp. 203-206, "The Inhibition of Glandular Kallikrein by Peptide Analog Antagonists of Bradykinin".
Slapke et al., (1986), Eur. J. Respir Dis., 68:pp. 29-34, "Protease Inhibitor Prevents Bronchoconstriction in Man".
Spragg et al., (1989, Adv. Exp. Med. Biol., 247B:pp. 277-281, "Inhibition of Human and Rat Tissue Kallikreins by Peptide Analog".
Abraham et al., (1991), Am. Rev. Respir. Dis., 143:pp. 787-796, "A Bradykinin Antagonist Modifies Allergen-Induced Mediator Release and Late Bronchial Responses in Sheep".
Soler et al., (1990), Pulmonary Pharmacology, 3:pp. 9-15, "A Bradykinin-Antagonist Blocks Antigen-Induced Airway Hyperresponsiveness and Inflammation in Sheep".
Caughey et al., (1988), J. Pharm. and Experimental Therapeutics, 244(1):133-137, "Substance P and Vasoactive Intestinal Peptide Degradation by Mast Cell Tryptase and Chymase".
Caughey, (1991), Am. J. Respir. Cell Mol. Biol., 4:pp. 387-394, "The Structure and Airway Biology of Mast Cell Proteinases".
Tidwell, (1978), J. Medicinal Chem., 21(7):pp. 613-623, "Diary-lamidine Derivatives with One or Both of the Aryl Moieties Consisting of an Indole or Indole-Like Ring. Inhibitors of Arginine-Specific Esteroproteases".
Barnes, (1991), British Medicine Bulletin 48(1):pp. 231-247, "New Therapeutic Approaches".
Sekizawa et al., (1989) J. Clin Invest., 83:pp. 175-179, "Mast Cell Tryptase Causes Airway Smooth Muscle Hyper-responsiveness in Dogs".
Franconi, et al., (1989), J. Pharm. and Experim. Therapeutics, 248(3) :pp. 947-951, "Mast Cell Tryptase and Chymase Reverse Airway Smooth Muscle Relaxation Induces by Vasoactive Intestinal Peptide in the Ferret".
Sturzebecher et al., (1992), Biol. chem. Hoppa-Seyer 373: pp. 1025-1030, "Inhibition of Human Mast Cell Tryptase by Benzamidine Derivatives".
Misawa et al., (1987), Japan J. Pharmocol., 43:pp. 53-60, "The Effect of Trans-4-Gaunidinomethylcyclohexanecarboxylic Acid p-tert-Butylphenyl Ester Hydrochloride (NCO-650) on Ascaris Suum Antigen-Induced Bronchoconstriction in Dogs".
Smith et al., (1984), J. Biol. Chem., 259(17):pp. 11046-11051, "Human Lung Tryptase".
Caughey, et al., (1987), Archives Biochem. and Biophysics., 258(2):pp. 555-563, "Dog Mastocytoma Tryptase: Affinity Purification, Characterization, and Amino-Terminal Sequence".
Oda et al., (1990), `Japan J. Pharmacol., 52:pp. 23-34, "Pharmacological Studies on 6-Amidino-2-Naphthy . . . and Anticomplement Activity In Vivo".
Matsuoka et al., (1989), Japan J. Pharmacol., 51:pp. 455-463, "Inhibitory Effects of ONO-3307 on Various Proteases and Tissue Thromboplastin In Vitro and on Experimental Thrombosis In Vivo".
Ueda et al., (1990), Biochem. J., 265:pp. 539-545, "The Synthesis of Arginylfluoroalkanes, Their Inhibition of Trypsin and Blood-Coagulation Serine Proteinases and Their Anticoagulant Activity".
Harvima et al., (1988), Biochimica et Biophysica Acta., 957:71-80, "Human Skin Tryptase: Purification, Partial Characterization and Comparison with Human Lung Tryptase".
Alter et al., 1990), Archives Biochem. and Biophysics., 276(1):pp. 26-31, "Interactions of Human Mast Cell Trypotase with Biological Protease Inhibitors".
Caughey et al., (1993), "Bis (5-Amidino-2-Benzimidazolyl) Methane and Related Amidines Are Potent, Reversible Inhibitors of Mast Cell Tryptases," J. Pharmacol. and Exper. Therapeutics, 264(2): 676. Galley proof submitted.
Walls et al., (1992), Biochem. Pharmacol., 43(6):pp. 1243-1248, Printed in Great Britain, "Human Mast Cell Tryptase Attenuates the Vasodilator Activity of Calcitonin Gene-Related Peptide".
Muramatsu et al., (1982), Hoppe-Seyler's Z. Physiol. Chem., Bd. 363, S. pp. 203-211, "Inhibitory Effects of Aryl . . . and Their Antiallergic Effects".
Vanderslice et al., (1990), Proc. Natl. Acad. Sci. USA, 87:pp. 3811-3815, "Human Mast Cell Tryptase: Multiple cDNAs and Genes Reveal a Multigene Serine Protease Family".
Miller et al., (1990), J. Clin. Invest., 864-870, "Cloning and Characterization of a Second Complementary DNA for Human Tryptase".
Miller et al., (1989), J. Clin. Invest., 84:pp. 1188-1195, "Cloning and Characterization of Complementary DNA for Human Tryptase".
Vanderslice et al., (1989), Am. Chem. Soc., 28:4148-4155, "Molecular Cloning of Dog Mast Cell Tryptase and a Related Protease: Structural Evidence of a Unique Mode of Serine Protease Activation".
Schwartz et al., (1987), N. Engl. J. Med., 316(26):pp. 1622-1626, "Tryptase Levels as an Indicator of Mast-Cell Activation in Systematic Anaphylaxis and Mastocytosis".
Castells et al., (1988), J. Allerg. Clin. Immunol., 82:pp. 348-355, "Tryptase Levels in Nasal-Lavage Fluid as an Indicator of the Immediate Allergic Response".
Broide et al., (1988), Am. Rev. Resp. Dis., 141:pp. 563-568, "Airway Levels of Mast Cell-Derived Mediators in Exercise-Induced Asthma".
Kalenderian et al., (1988), Chest, 94:pp. 119-123, "Elevated Histamine and Tryptase Levels in Smokers' Bronchoalveolar Lavage Fluid* Do Lung Mast Cells Contribute to Smokers' Emphysema".
Ruoss et al., (1991), J. Clin. Invest., 88:pp. 493-499, "Mast Cell Tryptase is a Mitogen for Cultured Fibroblasts".
Wenzel et al., "Activation of Pulmonary Mast Cells by Bronchoal-veolar Allergen Challenge," Am. Rev. Respir. Dis., 137: (5) pp. 1102-1108. (1987).
Gschwend Heinz W.
Johnson Charles
Spear Kerry
Arris Pharmaceutical Corporation
Richter Johann
LandOfFree
Compositions and methods for the treatment of immunomediated inf does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment of immunomediated inf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of immunomediated inf will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-351892